Science & Enterprise subscription

Follow us on Twitter

  • A company developing a treatment for Covid-19 infections taken as a tablet instead of infusion issued its initial p… https://t.co/iByygVnB9U
    about 16 hours ago
  • New post on Science and Enterprise: Covid-19 Drug Biotech Raises $300M in IPO https://t.co/zwkRakiFk5 #Science #Business
    about 16 hours ago
  • The Food and Drug Administration plans to use organ-on-chip models to test mechanisms for preventing Covid-19 infec… https://t.co/9zAfSK9Nnt
    about 21 hours ago
  • New post on Science and Enterprise: FDA to Use Lung Chip Model for Covid-19 Testing https://t.co/YGwasY1UUJ #Science #Business
    about 21 hours ago
  • Interim results from a clinical trial show a synthetic antibody drug reduces viral burden and medical visits among… https://t.co/bm7JdQ83hT
    about 2 days ago

Please share Science & Enterprise

DoD Funding Mobile Vaccine/Therapy Manufacturing Lab

DNAmolcule model

The U.S. Defense Department’s research agency is funding a prototype mobile lab to produce RNA-based vaccines and therapies in the field on demand. . . . → Read More: DoD Funding Mobile Vaccine/Therapy Manufacturing Lab

Group Advancing Electronic Spinal Cord Injury Therapies

Spine

A consortium of academic and industry labs is integrating electronic sensors and neural stimulation therapies into an early treatment protocol for spinal cord injuries. . . . → Read More: Group Advancing Electronic Spinal Cord Injury Therapies

DoD Funds Covid-19 G.I. Infection Therapy

Spirulina powder

A biotechnology company is developing biologic treatments for Covid-19 infections in the gastrointestinal tract and to block further disease transmission. . . . → Read More: DoD Funds Covid-19 G.I. Infection Therapy

DoD Funding Variable Covid-19 Vaccine Technology

SARS-Cov-2 virus

The U.S. Department of Defense is funding work on a Covid-19 vaccine platform that can adjust its formula to protect against future mutations in the virus. . . . → Read More: DoD Funding Variable Covid-19 Vaccine Technology

Biotech Gains Antibody Discovery, Manufacturing Funds

Global Covid-19

A Canadian biotechnology company is receiving government funds for Covid-19 antibody discovery and manufacturing for current and future pandemics. . . . → Read More: Biotech Gains Antibody Discovery, Manufacturing Funds

Covid-19 Antibody Therapy Prepares for Trial

Cattle

A biotechnology company producing synthetic antibodies in cattle, without human blood, to treat Covid-19 infections is advancing the therapy toward a clinical trial. . . . → Read More: Covid-19 Antibody Therapy Prepares for Trial

Small Biz Grant Funds PTSD Diagnostic, Treatment

Road-side bomb

A company creating diagnostics and a treatment for post-traumatic stress disorder, or PTSD, is receiving initial funding to develop its products. . . . → Read More: Small Biz Grant Funds PTSD Diagnostic, Treatment

AI-Based Discovery Seeks Non-Opioid Pain Drugs

Neuron

A new initiative aims to find non-opioid treatments for chronic pain targeting specific nerve cells that initiate pain sensations. . . . → Read More: AI-Based Discovery Seeks Non-Opioid Pain Drugs

Infographic – Private R&D Outpacing Defense Contractors

Private sector and defense R&D

Our infographic this weekend offers a stark illustration of how private companies have surpassed defense contractors in R&D spending. . . . → Read More: Infographic – Private R&D Outpacing Defense Contractors

Darpa Funds Early Disease Detection System

3-D print of influenza virus

The Defense Department’s advanced research agency is underwriting a system that gives an earlier notice of disease outbreaks and pandemics than current methods. . . . → Read More: Darpa Funds Early Disease Detection System